Literature DB >> 20101460

Reduced brain content of arachidonic acid and docosahexaenoic acid is related to the severity of liver fibrosis.

Chih-Cheng Chen1, Li-Tung Huang, You-Lin Tain, Hsio-Chi Chaung, Chih-Sung Hsieh, Hock-Liew Eng, Yu-Ching Wei, Chun-Yu Yang.   

Abstract

BACKGROUND: Cognitive deficiency noted post-liver transplantation might be a result of consequential metabolic derangement before liver transplantation. Long-chain polyunsaturated fatty acids, especially arachidonic acid (AA) and docosahexaenoic acid (DHA), affect the development of the central nervous system and its absorption is influenced by obstructive jaundice. AIM: To investigate the possible relationship between the brain content of AA and DHA with the severity of obstructive jaundice using a bile duct ligation rat model.
METHODS: Sprague-Dawley rats were divided into three groups: Sham (n = 5): rats received sham operation on P17 (17 days after delivery) and were sacrificed on P31; BDL2w (n = 5): rats received bile duct ligation and were sacrificed on P31; BDL4w (n = 7): rats received bile duct ligation and were sacrificed on P45. Liver function test, histopathology, and fatty acid composition of the brain tissues were analyzed. RESULT: The Sham group had significantly lowered total/direct bilirubin level (0.6 + 0.1/0.3 + 0.1 mg/dl) as compared to the BDL2w group (3.8 + 1.5/1.6 + 1.0 mg/dl) and the BDL4w group (4.3 + 0.6/3.3 + 0.5 mg/dl) (P = 0.04 and 0.008, respectively). Liver fibrosis and inflammatory changes of hepatocytes increased from the Sham group, the BDL2w group, to the BDL4w group. The Sham group had significantly higher AA and DHA content. The brain content of AA and DHA correlated negatively to the duration of bile duct ligation, the total/direct bilirubin level, and the degree of liver fibrosis.
CONCLUSION: Our results demonstrated that reduced AA and DHA content in the brain of rats which received bile duct ligation is closely related to both the severity of liver fibrosis and the impairment of liver function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101460     DOI: 10.1007/s10620-009-1120-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

Review 1.  The experience of women with primary biliary cirrhosis: a literature review.

Authors:  S Fahey
Journal:  J Adv Nurs       Date:  1999-08       Impact factor: 3.187

2.  Cholestatic liver diseases and health-related quality of life.

Authors:  Z M Younossi; M L Kiwi; N Boparai; L L Price; G Guyatt
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

Review 3.  Polyunsaturated fatty acid deficiency in liver diseases: pathophysiological and clinical significance.

Authors:  E Cabré; M A Gassull
Journal:  Nutrition       Date:  1996 Jul-Aug       Impact factor: 4.008

4.  Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.

Authors:  P M Huet; J Deslauriers; A Tran; C Faucher; J Charbonneau
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

Review 5.  Medium-chain triglyceride and n-3 polyunsaturated fatty acid-containing emulsions in intravenous nutrition.

Authors:  S Chan; K C McCowen; B Bistrian
Journal:  Curr Opin Clin Nutr Metab Care       Date:  1998-03       Impact factor: 4.294

6.  Prenatal protein depletion and Δ9, Δ6 and Δ5 desaturases in the rat.

Authors:  O Mercuri; M E de Tomás; H Itarte
Journal:  Lipids       Date:  1979-09       Impact factor: 1.880

7.  Cognitive patterns in school-age children with end-stage liver disease.

Authors:  S M Stewart; R A Campbell; D McCallon; D A Waller; W S Andrews
Journal:  J Dev Behav Pediatr       Date:  1992-10       Impact factor: 2.225

8.  Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failure.

Authors:  A Rimola; P Ginés; E Cusó; J Camps; J Gaya; V Arroyo; J Rodés
Journal:  Clin Sci (Lond)       Date:  1988-06       Impact factor: 6.124

9.  Essential fatty acid deficiency in malnourished children.

Authors:  R T Holman; S B Johnson; O Mercuri; H J Itarte; M A Rodrigo; M E De Tomas
Journal:  Am J Clin Nutr       Date:  1981-08       Impact factor: 7.045

10.  Quality of life in patients with primary biliary cirrhosis.

Authors:  Renée Eugénie Poupon; Yves Chrétien; Olivier Chazouillères; Raoul Poupon; Judith Chwalow
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

View more
  4 in total

Review 1.  Modulation of Toll-like receptor signaling in innate immunity by natural products.

Authors:  Luxi Chen; Jianhua Yu
Journal:  Int Immunopharmacol       Date:  2016-02-15       Impact factor: 4.932

2.  Cholestasis alters brain lipid and bile acid composition and compromises motor function in neonatal piglets.

Authors:  Nicole Lind Henriksen; Svend Høime Hansen; Matthew Domenic Lycas; Xiaoyu Pan; Thomas Eriksen; Lars Søndergaard Johansen; Richard R Sprenger; Christer Stenby Ejsing; Douglas G Burrin; Kerstin Skovgaard; Vibeke Brix Christensen; Thomas Thymann; Stanislava Pankratova
Journal:  Physiol Rep       Date:  2022-07

3.  Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats.

Authors:  Chih-Cheng Chen; Chun-Yi Ho; Hsio-Chi Chaung; You-Lin Tain; Chih-Sung Hsieh; Fang-Ying Kuo; Chun-Yu Yang; Li-Tung Huang
Journal:  Dig Dis Sci       Date:  2012-12-01       Impact factor: 3.199

4.  Potent natural products and herbal medicines for treating liver fibrosis.

Authors:  Shao-Ru Chen; Xiu-Ping Chen; Jin-Jian Lu; Ying Wang; Yi-Tao Wang
Journal:  Chin Med       Date:  2015-04-15       Impact factor: 5.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.